News Archive
Agricultural fungicide attracts honey bees, study finds
Diana Yates
When given the choice, honey bee foragers prefer to collect sugar syrup laced with the fungicide chlorothalonil over sugar syrup alone, researchers report in the journal Sci
Virus-bacteria coevolution solves diversity paradox by 'Killing the Winner'
Siv Schwink
There is remarkable biodiversity in all but the most extreme ecosystems on Earth.
Reach out and feed someone: Automated system finds rapid honey bee networks
Claudia Lutz
“Only connect”—E. M.
Unsuspected flexibility offers new pathway to cancer drug development
Claudia Lutz
Illinois research uncovers cross-system signaling activity by growth factors that direct blood vessel growth and influence the progression of cancer, stroke recovery, and ot
Alumnus funds graduate students researching brain tissue cultures
Emily Scott
Scott Fisher believes learning how to solve a problem can be as valuable as solving one.
Researchers establish long-sought source of ocean methane
Anne Trafton, MIT News Office, and Claudia Lutz
BIomarker Vol. 11 Now Available
Biomarker, the annual IGB magazine, is now available!
Team receives funding to study bacterial community dynamics
Bioengineering communications office
There is still much to understand about the dynamics of bacterial communities in the human gut, as well as how bacteria behave en masse in a biofilm, a collective of…
Viruses share genes with organisms across the tree of life
Diana Yates
A new study finds that viruses share some genes exclusively with cells that are not their hosts.
In microbe populations, bioengineers find balance of opposing genomic forces
Claudia Lutz
Sergei Maslov, a professor of bioengineering and physics at the University of Illinois, sees a “universe in a grain of sand.” His research seeks to explore that universe by…
A new way to do metabolic engineering
Emily Scott
A novel method developed by a group of IGB researchers could change the way metabolic engineering is done.
Cancer drug starts clinical trials in human brain-cancer patients
Diana Yates
A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anapl